Becker's Healthcare July 9, 2024
Ashleigh Hollowell

Eighty-five days shy of October, the month when respiratory virus season typically begins in the U.S., the CDC and FDA have already made several key announcements about what clinicians can expect for the 2024-2025 round of vaccines for the infections that dominate during this time of year: influenza, respiratory syncytial virus and COVID-19.

Below are the most recent recommendations for the upcoming round of vaccines:

Flu

The 2024-2025 flu vaccines are recommended by the CDC for everyone 6 months of age and older. This year, the flu vaccine will likely transition back to a trivalent composition, removing the B/Yamagata lineage virus as a component.

“Influenza B viruses are classified into two lineages: B/Yamagata and B/Victoria,” a March FDA committee recommendation...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Related Articles:
Crackdown on Homeless Encampments Raises Public Health Questions
FDA approves 1st RSV vaccine for adults under 60
Beyond Floppy Disks And Fax Machines: Modernizing Immunization Information Systems
XEC poised to become dominant COVID variant: Preprint study
PCPs Can Help Ease This ‘Public Health Catastrophe’

Share This Article